[1]黄洁夫, 湛海伦, 刘小彭, 等. 尿源性脓毒血症的防治[J]. 中华临床医师杂志:电子版, 2012, 6(7): 164-166.
[2]Guliciuc M, Maier A C, Maier I M, et al. The urosepsis-a literature review[J]. Medicina, 2021, 57(9): 872.
[3]Rudd K E, Johnson S C, Agesa K M, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395(10219): 200-211.
[4]Oduncu A F, Kıyan G S, Yalçınlı S. Comparison of qSOFA, SIRS, and NEWS scoring systems for diagnosis, mortality, and morbidity of sepsis in emergency department[J]. Am J Emerg Med, 2021, 48: 54-59.
[5]那彦群, 叶章群, 孙光, 等. 中国泌尿外科疾病诊断治疗指南手册[M]. 北京: 人民卫生出版社, 2014.
[6]臧海洋, 王勤章, 钱彪, 等. 输尿管软镜相关尿源性脓毒血症相关危险因素的Meta分析[J]. 农垦医学, 2019, 41(1): 17-22.
[7]夏晴晴. 249例围绝经期妇女尿路感染的病原菌与药敏性分析[J]. 中国妇幼保健, 2015, 30(13): 2033-2035.
[8]白国兰, 任惠芳, 闫平. 62例围绝经期妇女尿路感染的诊断治疗分析[J]. 内蒙古中医药, 2013, 32(20): 89.
[9]Koh G C K W, Peacock S J, van der Poll T, et al. The impact of diabetes on the pathogenesis of sepsis[J]. Eur J Clin Microbiol Infect Dis, 2012, 31(4): 379-388.
[10]侯飞飞. 输尿管软镜碎石术中肾盂内压力的监控及意义[J]. 中国微创外科杂志, 2018, 18(1): 75-77.
[11]张开能, 柯昌兴. 输尿管软镜联合负压吸引鞘治疗直径2~2.5 cm肾结石的疗效分析[J]. 东南国防医药, 2022, 24(2): 196-198.
[12]熊波波, 张劲松, 李宁, 等. 硕通镜和输尿管镜钬激光在输尿管上段感染性结石疗效对比[J]. 临床泌尿外科杂志, 2020, 35(7): 566-570.
[13]毛俊彪,袁平成, 桂定文, 等. 输尿管软镜钬激光碎石术后尿源性脓毒血症5例分析及对策[J]. 微创泌尿外科杂志, 2015, 4(4): 221-223.
[14]陈斌, 白培德. 负压技术在输尿管镜治疗上尿路结石应用的中国专家共识(2023年)[J]. 临床泌尿外科杂志, 2023, 38(8): 565-568.
[15]Wu H Y, Zhu S B, Yu S C, et al. Early drastic decrease in white blood count can predict uroseptic shock induced by upper urinary tract endoscopic lithotripsy: a translational study[J]. J Urol, 2015, 193(6): 2116-2122.
[16]Bartoletti M, Antonelli M, Bruno Blasi F A, et al. Procalcitonin-guided antibiotic therapy: an expert consensus[J]. Clin Chem Lab Med, 2018, 56(8): 1223-1229.
[17]降钙素原急诊临床应用专家共识组. 降钙素原(PCT)急诊临床应用的专家共识[J]. 中华急诊医学杂志, 2012, 21(9): 944-951.
[18]谭乐明, 杨成, 杨旭凯, 等. 尿源性脓毒血症严重程度的相关因素分析[J]. 南方医科大学学报, 2019, 39(1): 93-99.
[19]窦全亮, 贾瑞鹏. 上尿路结石并发重症尿源性脓毒血症危险因素分析[J]. 山东医药, 2018, 58(39): 77-79.
[20]Kumar A, Roberts D, Wood K E, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock[J]. Crit Care Med, 2006, 34(6): 1589-1596.
[21]王璨, 胡雪莲, 赵语. 降钙素原对尿源性脓毒血症早期诊断价值的meta分析[J]. 重庆医学, 2022, 51(6): 1029-1034.
[22]Bouadma L, Luyt C E, Tubach F, et al. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial[J]. Lancet, 2010, 375(9713): 463-474.
[23]Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021[J]. Intensive Care Med, 2021, 47(11): 1181-1247.
|